Cargando…

Methicillin-resistant Staphylococcus aureus development in intensive care patients: A case-control study

OBJECTIVES: To determine the factors associated with the development of methicillin-resistant Staphylococcus aureus (MRSA), hospital stay and mortality, and early versus late MRSA infection. METHODS: Cases (n=44) were intensive care unit (ICU) patients admitted to King Fahd Specialist Hospital, Al-Q...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Mohamed A., Rajab, Ahmad M., Al-Khani, Abdullah M., Ayash, Saleh Q., Basha, Amjad Chamsi, Abdelgadir, Ahmed, Rajab, Tawfik M., Enabi, Saed, Saquib, Nazmus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Saudi Medical Journal 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804236/
https://www.ncbi.nlm.nih.gov/pubmed/33130837
http://dx.doi.org/10.15537/smj.2020.11.25465
_version_ 1783636117926445056
author Ali, Mohamed A.
Rajab, Ahmad M.
Al-Khani, Abdullah M.
Ayash, Saleh Q.
Basha, Amjad Chamsi
Abdelgadir, Ahmed
Rajab, Tawfik M.
Enabi, Saed
Saquib, Nazmus
author_facet Ali, Mohamed A.
Rajab, Ahmad M.
Al-Khani, Abdullah M.
Ayash, Saleh Q.
Basha, Amjad Chamsi
Abdelgadir, Ahmed
Rajab, Tawfik M.
Enabi, Saed
Saquib, Nazmus
author_sort Ali, Mohamed A.
collection PubMed
description OBJECTIVES: To determine the factors associated with the development of methicillin-resistant Staphylococcus aureus (MRSA), hospital stay and mortality, and early versus late MRSA infection. METHODS: Cases (n=44) were intensive care unit (ICU) patients admitted to King Fahd Specialist Hospital, Al-Qassim, Saudi Arabia between 2015 and 2019 who developed MRSA during their hospital stay. Controls (n=48) were patients from the same place and period who did not develop MRSA. Data were abstracted from hospital records. RESULTS: Admission with sepsis (case: 46% vs. control: 2%, p<0.001) and having at least one comorbid condition (case: 95% vs. control: 46%, p<0.001) were significantly associated with the development of MRSA. Age (mean ± SD: case: 65±18, control: 64±18, p=0.7) and gender (% male, case: 52%, control: 56%, p=0.70) were not associated with the development of MRSA. Approximately 73% of all MRSA cases developed within the first 2 weeks of admission. Among the early cases, 44% died during their ICU stay; the corresponding percentage among the late cases was 42% (p=0.69). There was no difference between early and late MRSA cases in terms of non-sepsis admissions (50% vs. 67%, p=0.32) or comorbid status (at least one: 97% vs. 92%, p=0.17). CONCLUSION: Sepsis and comorbid conditions were significant risk factors for MRSA development among hospital patients.
format Online
Article
Text
id pubmed-7804236
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Saudi Medical Journal
record_format MEDLINE/PubMed
spelling pubmed-78042362021-03-11 Methicillin-resistant Staphylococcus aureus development in intensive care patients: A case-control study Ali, Mohamed A. Rajab, Ahmad M. Al-Khani, Abdullah M. Ayash, Saleh Q. Basha, Amjad Chamsi Abdelgadir, Ahmed Rajab, Tawfik M. Enabi, Saed Saquib, Nazmus Saudi Med J Original Article OBJECTIVES: To determine the factors associated with the development of methicillin-resistant Staphylococcus aureus (MRSA), hospital stay and mortality, and early versus late MRSA infection. METHODS: Cases (n=44) were intensive care unit (ICU) patients admitted to King Fahd Specialist Hospital, Al-Qassim, Saudi Arabia between 2015 and 2019 who developed MRSA during their hospital stay. Controls (n=48) were patients from the same place and period who did not develop MRSA. Data were abstracted from hospital records. RESULTS: Admission with sepsis (case: 46% vs. control: 2%, p<0.001) and having at least one comorbid condition (case: 95% vs. control: 46%, p<0.001) were significantly associated with the development of MRSA. Age (mean ± SD: case: 65±18, control: 64±18, p=0.7) and gender (% male, case: 52%, control: 56%, p=0.70) were not associated with the development of MRSA. Approximately 73% of all MRSA cases developed within the first 2 weeks of admission. Among the early cases, 44% died during their ICU stay; the corresponding percentage among the late cases was 42% (p=0.69). There was no difference between early and late MRSA cases in terms of non-sepsis admissions (50% vs. 67%, p=0.32) or comorbid status (at least one: 97% vs. 92%, p=0.17). CONCLUSION: Sepsis and comorbid conditions were significant risk factors for MRSA development among hospital patients. Saudi Medical Journal 2020-11 /pmc/articles/PMC7804236/ /pubmed/33130837 http://dx.doi.org/10.15537/smj.2020.11.25465 Text en Copyright: © Saudi Medical Journal http://creativecommons.org/licenses/by-nc This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial License (CC BY-NC), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ali, Mohamed A.
Rajab, Ahmad M.
Al-Khani, Abdullah M.
Ayash, Saleh Q.
Basha, Amjad Chamsi
Abdelgadir, Ahmed
Rajab, Tawfik M.
Enabi, Saed
Saquib, Nazmus
Methicillin-resistant Staphylococcus aureus development in intensive care patients: A case-control study
title Methicillin-resistant Staphylococcus aureus development in intensive care patients: A case-control study
title_full Methicillin-resistant Staphylococcus aureus development in intensive care patients: A case-control study
title_fullStr Methicillin-resistant Staphylococcus aureus development in intensive care patients: A case-control study
title_full_unstemmed Methicillin-resistant Staphylococcus aureus development in intensive care patients: A case-control study
title_short Methicillin-resistant Staphylococcus aureus development in intensive care patients: A case-control study
title_sort methicillin-resistant staphylococcus aureus development in intensive care patients: a case-control study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804236/
https://www.ncbi.nlm.nih.gov/pubmed/33130837
http://dx.doi.org/10.15537/smj.2020.11.25465
work_keys_str_mv AT alimohameda methicillinresistantstaphylococcusaureusdevelopmentinintensivecarepatientsacasecontrolstudy
AT rajabahmadm methicillinresistantstaphylococcusaureusdevelopmentinintensivecarepatientsacasecontrolstudy
AT alkhaniabdullahm methicillinresistantstaphylococcusaureusdevelopmentinintensivecarepatientsacasecontrolstudy
AT ayashsalehq methicillinresistantstaphylococcusaureusdevelopmentinintensivecarepatientsacasecontrolstudy
AT bashaamjadchamsi methicillinresistantstaphylococcusaureusdevelopmentinintensivecarepatientsacasecontrolstudy
AT abdelgadirahmed methicillinresistantstaphylococcusaureusdevelopmentinintensivecarepatientsacasecontrolstudy
AT rajabtawfikm methicillinresistantstaphylococcusaureusdevelopmentinintensivecarepatientsacasecontrolstudy
AT enabisaed methicillinresistantstaphylococcusaureusdevelopmentinintensivecarepatientsacasecontrolstudy
AT saquibnazmus methicillinresistantstaphylococcusaureusdevelopmentinintensivecarepatientsacasecontrolstudy